CASC2 and hepatocellular carcinoma: Furthermore, CASC2 has been shown to inhibit HCC by acting as a ceRNA for miR-362-5p, which resulted in the inhibition of the Nuclear Factor Kappa Beta (NF-κB) pathway [137].